Changes of biomarkers with oral exposure to benzo(a)pyrene, phenanthrene and pyrene in rats.
- Author:
Hwan Goo KANG
1
;
Sang Hee JEONG
;
Myung Haing CHO
;
Joon Hyoung CHO
Author Information
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords: benzo(a)pyrene; biomarker; PAHs; phenanthrene; pyrene
- MeSH: Adipose Tissue/chemistry/drug effects; Animals; Benzo(a)pyrene/analysis/metabolism/*toxicity; Biological Markers/metabolism/urine; Blood Chemical Analysis; Body Weight/drug effects; Cytochrome P-450 CYP1A1/metabolism; Environmental Pollutants/blood/metabolism/*toxicity/urine; Female; Liver/drug effects/enzymology; Lymphocytes/drug effects/metabolism; Muscle, Skeletal/drug effects/metabolism; Organ Size/drug effects; Phenanthrenes/blood/metabolism/*toxicity/urine; Pyrenes/analysis/metabolism/*toxicity; Rats; Rats, Sprague-Dawley; Time Factors
- From:Journal of Veterinary Science 2007;8(4):361-368
- CountryRepublic of Korea
- Language:English
- Abstract: Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental contaminants present in air and food. Among PAHs, benzo(a)pyrene(BaP), phenanthrene (PH) and pyrene (PY) are considered to be important for their toxicity or abundance. To investigate the changes of biomarkers after PAH exposure, rats were treated with BaP (150 microgram/kg) alone or with PH (4,300 microgram/kg) and PY (2,700 microgram/kg) (BPP group) by oral gavage once per day for 30 days. 7-ethoxyresorufin-O-deethylase activity in liver microsomal fraction was increased in only BaP groups. The highest concentration (34.5 ng/g) of BaP, was found in muscle of rats treated with BaP alone at 20 days of treatment; it was 23.6 ng/g in BPP treated rats at 30 days of treatment. The highest PH concentration was 47.1 ng/g in muscle and 118.8 ng/g in fat, and for PY it was 29.7 ng/g in muscle and 219.9 ng/g in fat, in BPP groups. In urine, 114-161 ng/ml 3-OH-PH was found, while PH was 41-69 ng/ml during treatment. 201-263 ng/ml 1-OH-PY was found, while PH was 9-17 ng/ml in urine. The level of PY, PH and their metabolites in urine was rapidly decreased after withdrawal of treatment. This study suggest that 1-OH-PY in urine is a sensitive biomarker for PAHs; it was the most highly detected marker among the three PAHs and their metabolites evaluated during the exposure period and for 14 days after withdrawal.
